Description
Dermal Fillers Market Analysis
Market Overview
The rising popularity of cosmetic surgery is anticipated to be a key driver of market growth throughout the forecast period. It is projected that during the assessment period, the rising popularity of facial operations among both men and women will have a significant impact on market growth.
In addition, main players’ ongoing technical advancement in dermal fillers is anticipated to be advantageous for the sector in the coming years. Over the time of the investigation, the market has benefited significantly from the rising demand for minimally invasive procedures. To match the growing demand, manufacturers are releasing a variety of cutting-edge products, which is expected to spur growth in the ensuing period.
Segment Overview
The Global Dermal Fillers market consists of three main types of segment insights: Type, Application, and Brand.
Hyaluronic acid is anticipated to experience the highest CAGR of any form of dermal filler throughout the projection period.
The lip treatment and facial line correcting treatment segments are estimated to generate strong market worth during the forecast timeframe in the application section of a global dermal fillers market.
The Americas is anticipated to gain the biggest market share throughout the analysis period, according to MRFR’s report on the dermal fillers market.
Regional Analysis
The Americas is anticipated to gain the biggest market share throughout the analysis period, according to this report on the dermal fillers market. The rising necessity for minimally invasive facial surgeries and the rising demand for cosmetic items both contribute to the regional market’s expansion. Also, the expanding number of clinical studies for cutting-edge skin beauty products is projected to further stimulate the local market. The US is expected to contribute significantly to the growth of the regional market among all the countries in the region.
Over the projected period, Europe is anticipated to hold the second-largest market share for dermal fillers. The region’s market is expected to be significantly influenced by the rising popularity of minimally-invasive methods of face enhancement in the ensuing years. Another significant factor that is anticipated to boost the sales of cosmetic procedures in the region is the rising number of product licenses and product access throughout the region.
Major Players
Suneva Medical (US), Sinclair Pharma (UK), Medytox (South Korea), Merz Pharma (Germany), SciVision Biotech Inc. (Taiwan), Galderma Laboratories, LP (Switzerland), Allergan (Ireland), Dr. Korman Laboratories (Israel), and Teoxane Laboratories (Switzerland) are a few of the companies that work for the Global Dermal Fillers.
COVID 19 Impacts
The research predicts that the coronavirus outbreak will have a detrimental effect on the world market. In 2018, the market is probably going to have a 40% decline from 2019. The lockdown that was imposed on a global front resulted in the closure of numerous cosmetic facilities and clinics.
The number of cosmetic procedures is declining due to the rising incidence of coronavirus, which has a detrimental effect on the size of the dermal fillers industry. Dermal fillers are frequently utilised in procedures that are minimally invasive as a facial firmness and wrinkle-reduction anti-aging treatment.
Several types of products are used with dermal fillers to improve the look of scars, eliminate wrinkles, soften face creases, and enhance shallow contours. Dermal fillers are becoming more widely accepted among people of all ages as awareness of the advantages they have over surgical procedures grows.
The global market for dermal fillers is being impacted by the corona virus pandemic. the COVID-19 corona virus illness outbreak in 2018. As of right today, it has killed 281,736 individuals and impacted more over 4 million people worldwide.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW 13
1.1.1 MARKET SYPNOSIS 14
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY 15
2.2 RESEARCH OBJECTIVE 15
2.3 LIST OF ASSUMPTIONS 15
3 RESEARCH METHODOLOGY
3.1 OVERVIEW 17
3.2 DATA MINING 17
3.3 SECONDARY RESEARCH 18
3.4 PRIMARY RESEARCH 19
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 19
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 20
3.5 FORECASTING TECHNIQUES 20
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21
3.6.1 BOTTOM-UP APPROACH 22
3.6.2 TOP-DOWN APPROACH 23
3.7 DATA TRIANGULATION 24
3.8 VALIDATION 24
4 MARKET DYNAMICS
4.1 OVERVIEW 25
4.2 DRIVERS 26
4.2.1 GROWING DEMAND FOR FACIAL AESTHETICS GLOBALLY 26
4.2.2 INCREASING NUMBER OF AESTHETIC PROCEDURES PERFORMED BY PLASTIC SURGEONS 26
4.2.3 COST-EFFECTIVE ALTERNATIVE TO COSMETIC SURGERIES 26
4.2.4 RESTRAINTS 28
4.2.5 SIDE-EFFECTS ASSOCIATED WITH DERMAL FILLERS 28
4.2.6 BLACK MARKET OF DERMAL FILLERS AND EFFECTS OF UNREGISTERED PRACTITIONERS 29
4.3 OPPORTUNITIES 30
4.3.1 INCREASING NUMBER OF CLINICAL TRIAL STUDIES 30
4.3.2 RISING DEMAND FOR MINIMALLY INVASIVE PROCEDURES 30
5 MARKET FACTOR ANALYSIS
5.1 PORTERS FIVE FORCES 31
5.1.1 THREAT OF NEW ENTRANTS 32
5.1.2 BARGAINING POWER OF SUPPLIERS 32
5.1.3 THREAT OF SUBSTITUTES 32
5.1.4 BARGAINING POWER OF BUYERS 32
5.1.5 INTENSITY OF RIVALRY 32
5.2 VALUE CHAIN ANALYSIS 33
5.2.1 RESEARCH AND DEVELOPMENT 34
5.2.2 MANUFACTURING PROCESS OF AESTHETIC PRODUCTS 34
5.2.3 MARKETING AND DISTRIBUTION 34
6 DERMAL FILLERS MARKET, BY TYPE
6.1 OVERVIEW 35
6.2 HYALURONIC ACID 36
6.3 POLYMERS & PARTICLES 36
6.4 CALCIUM HYDROXYLAPATITE 37
6.5 COLLAGEN 37
7 DERMAL FILLERS MARKET, BY BRAND
7.1 OVERVIEW 38
7.2 JUVEDERM 39
7.3 RADIESSE 39
7.4 RESTYLANE 40
8 DERMAL FILLERS MARKET, BY APPLICATION
8.1 OVERVIEW 41
8.2 FACIAL LINE CORRECTION TREATMENT 42
8.3 FACE-LIFT 42
8.4 LIP TREATMENTS 43
9 GLOBAL DERMAL FILLERS MARKET, BY REGION
9.1 OVERVIEW 44
9.2 AMERICAS 46
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.2.1 NORTH AMERICA 48
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.2.1.1 US 49
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.2.1.2 CANADA 50
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.2.2 LATIN AMERICA 51
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.3 EUROPE 53
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.3.1 GERMANY 55
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.3.2 UK 56
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.3.3 FRANCE 57
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.3.4 ITALY 58
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.3.5 SPAIN 59
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.3.6 REST OF EUROPE 60
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.4 ASIA-PACIFIC 61
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.4.1 JAPAN 63
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.4.2 CHINA 64
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.4.3 SOUTH KOREA 65
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.4.4 INDIA 66
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.4.5 SINGAPORE 67
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.4.6 MALAYSIA 68
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.4.7 INDONESIA 69
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.4.8 REST OF ASIA-PACIFIC 70
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.5 MIDDLE EAST AND AFRICA 71
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.5.1 MIDDLE EAST 73
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
9.5.2 AFRICA 74
DERMAL FILLERS MARKET, BY TYPE
DERMAL FILLERS MARKET, BY BRAND
DERMAL FILLERS MARKET, BY APPLICATION
10 COMPETITIVE LANDSCAPE: GLOBAL DERMAL FILLERS MARKET
10.1 OVERVIEW 76
10.2 COMPETITIVE ANALYSIS 76
10.3 COMPETITOR DASHBOARD 77
10.4 COMPETITIVE BENCHMARKING 78
10.5 MAJOR GROWTH STRATEGY IN THE GLOBAL DERMAL FILLERS MARKET 79
10.6 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS 79
10.7 KEY DEVELOPMENTS AND GROWTH STRATEGIES 80
10.7.1 ACQUISITION 80
10.7.2 PRODUCT APPROVAL AND LAUNCH 80
10.7.3 EXPANSION 81
10.8 MAJOR PLAYERS FINANCIAL MATRIX & MARKET RATIO 82
10.8.1 SALES 82
10.8.2 R&D EXPENDITURE 82
11 COMPANY PROFILES
11.1 GALDERMA LABORATORIES, L.P. 83
11.1.1 COMPANY OVERVIEW 83
11.1.2 FINANCIAL OVERVIEW 83
11.1.3 PRODUCTS/SERVICES OFFERED 83
11.1.4 KEY DEVELOPMENTS 83
11.1.5 SWOT ANALYSIS 84
11.1.6 KEY STRATEGIES 84
11.2 ALLERGAN 85
11.2.1 COMPANY OVERVIEW 85
11.2.2 FINANCIAL OVERVIEW 85
11.2.3 PRODUCTS/SERVICES OFFERED 86
11.2.4 ALLERGAN: KEY DEVELOPMENTS 86
11.2.5 SWOT ANALYSIS 87
11.2.6 KEY STRATEGIES 87
11.3 MERZ PHARMA 88
11.3.1 COMPANY OVERVIEW 88
11.3.2 FINANCIAL OVERVIEW 88
11.3.3 PRODUCTS/SERVICES OFFERED 89
11.3.4 KEY DEVELOPMENTS 89
11.3.5 SWOT ANALYSIS 90
11.3.6 KEY STRATEGIES 90
11.4 DR. KORMAN LABORATORIES 91
11.4.1 COMPANY OVERVIEW 91
11.4.2 FINANCIAL OVERVIEW 91
11.4.3 PRODUCTS/SERVICES OFFERED 91
11.4.4 KEY DEVELOPMENTS 91
11.4.5 SWOT ANALYSIS 92
11.4.6 KEY STRATEGIES 92
11.5 SINCLAIR PHARMA 93
11.5.1 COMPANY OVERVIEW 93
11.5.2 FINANCIAL OVERVIEW 93
11.5.3 PRODUCTS/SERVICES OFFERED 94
11.5.4 KEY DEVELOPMENTS 94
11.5.5 SWOT ANALYSIS 94
11.5.6 KEY STRATEGIES 95
11.6 TEOXANE LABORATORIES 96
11.6.1 COMPANY OVERVIEW 96
11.6.2 FINANCIAL OVERVIEW 96
11.6.3 PRODUCTS/SERVICES OFFERED 96
11.6.4 KEY DEVELOPMENTS 97
11.6.5 SWOT ANALYSIS 97
11.6.6 KEY STRATEGIES 97
11.7 SUNEVA MEDICAL 98
11.7.1 COMPANY OVERVIEW 98
11.7.2 FINANCIAL OVERVIEW 98
11.7.3 PRODUCTS/SERVICES OFFERED 98
11.7.4 KEY DEVELOPMENTS 98
11.7.5 SWOT ANALYSIS 99
11.7.6 KEY STRATEGIES 99
11.8 SCIVISION BIOTECH INC. 100
11.8.1 COMPANY OVERVIEW 100
11.8.2 FINANCIAL OVERVIEW 100
11.8.3 PRODUCTS/SERVICES OFFERED 100
11.8.4 KEY DEVELOPMENTS 100
11.8.5 SWOT ANALYSIS 101
11.8.6 KEY STRATEGIES 101
11.9 MEDYTOX 102
11.9.1 COMPANY OVERVIEW 102
11.9.2 FINANCIAL OVERVIEW 102
11.9.3 PRODUCTS/SERVICES OFFERED 102
11.9.4 KEY DEVELOPMENTS 102
11.9.5 SWOT ANALYSIS 103
11.9.6 KEY STRATEGIES 103
12 APPENDIX
12.1 REFERENCES 104
12.2 RELATED REPORTS 104″
